Profile
| Metric | Value |
|---|---|
| Full Name | MBX Biosciences, Inc. |
| Ticker | NASDAQ: MBX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | mbxbio.com |
| Employees | 43 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $32.65 | |
| Price, 1D Change | +13.76% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.49 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$1.85 | |
| EPS, 1Y Change | -89.91% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.85 | |
| EPS Estimate | -$2.54 | |
| EPS Est. Change | -37.01% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $32.65 | |
| Price Target | - | $61.50 |
| Price Tgt. Change | - | +88.36% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$13.25 | -$1.85 | +86.01% | |
| -$2.54 | N/A | -37.01% | |
| -$3.19 | N/A | -72.33% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +123.63% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +124.78% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -89.91% | |
| EPS, 3Y | -136.63% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $32.65 | |
| SMA 200 | $15.91 | |
| SMA 200 vs Price | -51.26% | |
| SMA 50 | $27.64 | |
| SMA 50 vs Price | -15.34% | |
| Beta | 1.49 | |
| ATR | $2.21 | |
| 14-Day RSI | 46.75 | |
| 10-Day Volatility | 93.34% | |
| 1-Year Volatility | 138.47% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$1.85 | |
| Gross Profit | -$244.00K | |
| - | ||
| Operating Profit | -$68.19M | |
| - | ||
| Net Income | -$61.92M | |
| - | ||
| EBITDA | -$67.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| 24.19 | ||
| 24.19 | ||
| - | ||
| - | ||
| 58.92 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 2.83 | ||
| -7.80 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $257.44M | |
| $49.35M | ||
| $268.54M | ||
| $267.29M | ||
| $11.09M | ||
| $11.05M | ||
| Total Debt | $213.00K | |
| $171.00K | ||
| $5.34M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $68.19M | ||
| $68.19M | ||
| $244.00K | ||
| $10.78M | ||
| $244.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$54.68M | ||
| -$160.60M | ||
| $234.10M | ||
| Capex | $874.00K | |
| -$55.56M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Stifel | → | |
| Goldman Sachs | ||
| Guggenheim | → | |
| TD Cowen | ||
| Truist Securities | ||
| Mizuho | → | |
| Oppenheimer | → | |
| Guggenheim | → | |
| Mizuho | ||
| Oppenheimer |
Analyst sentiment
Institutional ownership
Screeners with MBX
Data Sources & References
- MBX Official Website mbxbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1776111/000119312525268148/0001193125-25-268148-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776111/000095017025039838/0000950170-25-039838-index.htm
- MBX Profile on Yahoo Finance finance.yahoo.com/quote/MBX
- MBX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mbx
FAQ
What is the ticker symbol for MBX Biosciences, Inc.?
The ticker symbol for MBX Biosciences, Inc. is NASDAQ:MBX
Does MBX Biosciences, Inc. pay dividends?
No, MBX Biosciences, Inc. does not pay dividends
What sector is MBX Biosciences, Inc. in?
MBX Biosciences, Inc. is in the Healthcare sector
What industry is MBX Biosciences, Inc. in?
MBX Biosciences, Inc. is in the Biotechnology industry
What country is MBX Biosciences, Inc. based in?
MBX Biosciences, Inc. is headquartered in United States
When did MBX Biosciences, Inc. go public?
MBX Biosciences, Inc. initial public offering (IPO) was on January 14, 2000
Is MBX Biosciences, Inc. in the S&P 500?
No, MBX Biosciences, Inc. is not included in the S&P 500 index
Is MBX Biosciences, Inc. in the NASDAQ 100?
No, MBX Biosciences, Inc. is not included in the NASDAQ 100 index
Is MBX Biosciences, Inc. in the Dow Jones?
No, MBX Biosciences, Inc. is not included in the Dow Jones index
When was MBX Biosciences, Inc. last earnings report?
MBX Biosciences, Inc.'s most recent earnings report was on November 6, 2025
When does MBX Biosciences, Inc. report earnings?
The next expected earnings date for MBX Biosciences, Inc. is March 16, 2026